Understanding hesitancy with revealed preferences across COVID-19 vaccine types

被引:0
|
作者
Kristóf Kutasi
Júlia Koltai
Ágnes Szabó-Morvai
Gergely Röst
Márton Karsai
Péter Biró
Balázs Lengyel
机构
[1] Rice University,Department of Economics
[2] Computational Social Science-Research Center for Educational and Network Studies,Centre for Social Sciences
[3] Eötvös Loránd University,Faculty of Social Sciences
[4] Central European University,Department of Network and Data Science
[5] Eötvös Loránd Research Network,Health and Population Lendület Research Group
[6] Centre for Economic and Regional Studies,Department of Economics
[7] Debrecen University,Bolyai Institute
[8] University of Szeged,Mechanism Design Lendület Research Group
[9] Alfréd Rényi Institute of Mathematics,Department of Operations Research and Actuarial Sciences
[10] Eötvös Loránd Research Network,Agglomeration and Social Networks Lendület Research Group
[11] Centre for Economic and Regional Studies,Corvinus Institute for Advanced Studies
[12] Corvinus University of Budapest,undefined
[13] Eötvös Loránd Research Network,undefined
[14] Centre for Economic and Regional Studies,undefined
[15] Corvinus University of Budapest,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Many countries have secured larger quantities of COVID-19 vaccines than their population is willing to take. The abundance and the large variety of vaccines created not only an unprecedented intensity of vaccine related public discourse, but also a historical moment to understand vaccine hesitancy better. Yet, the heterogeneity of hesitancy by vaccine types has been neglected in the existing literature so far. We address this problem by analysing the acceptance and the assessment of five vaccine types. We use information collected with a nationally representative survey at the end of the third wave of the COVID-19 pandemic in Hungary. During the vaccination campaign, individuals could reject the assigned vaccine to wait for a more preferred alternative that enables us to quantify revealed preferences across vaccine types. We find that hesitancy is heterogenous by vaccine types and is driven by individuals’ trusted source of information. Believers of conspiracy theories are more likely to evaluate the mRNA vaccines (Pfizer and Moderna) unacceptable. Those who follow the advice of politicians are more likely to evaluate vector-based (AstraZeneca and Sputnik) or whole-virus vaccines (Sinopharm) acceptable. We argue that the greater selection of available vaccine types and the free choice of the individual are desirable conditions to increase the vaccination rate in societies.
引用
收藏
相关论文
共 50 条
  • [1] Understanding hesitancy with revealed preferences across COVID-19 vaccine types
    Kutasi, Kristof
    Koltai, Julia
    Szabo-Morvai, Agnes
    Rost, Gergely
    Karsai, Marton
    Biro, Peter
    Lengyel, Balazs
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [2] Understanding COVID-19 vaccine hesitancy
    Shingai Machingaidze
    Charles Shey Wiysonge
    Nature Medicine, 2021, 27 : 1338 - 1339
  • [3] Understanding vaccine hesitancy in COVID-19
    Trogen, Brit
    Pirofski, Liise-anne
    MED, 2021, 2 (05): : 498 - 501
  • [4] Understanding COVID-19 vaccine hesitancy
    Machingaidze, Shingai
    Wiysonge, Charles Shey
    NATURE MEDICINE, 2021, 27 (08) : 1338 - 1339
  • [5] Understanding COVID-19 vaccine hesitancy in Canada
    Corsten, Claire
    Vang, Zoua M.
    Gold, Ian
    Goldenberg, Maya J.
    Juarez, Fernanda Perez-Gay
    Weinstock, Daniel
    Smith, Maxwell J.
    Krajden, Oren
    Solomonova, Elizaveta
    VACCINE, 2023, 41 (48) : 7274 - 7280
  • [6] Understanding COVID-19 vaccine hesitancy in pregnant patients
    Cui, Yiwen
    Binger, Kole S.
    Tsaih, Shirng-Wern
    Palatnik, Anna
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2022, 226 (01) : S658 - S658
  • [7] Understanding COVID-19 vaccine hesitancy in vasculitis patients
    Butt, Imama N.
    van Eeden, Charmaine
    Kovacs Burns, Katharina
    Saxinger, Lynora
    Clifford, Alison
    Redmond, Desiree
    Cohen Tervaert, Jan Willem
    Yacyshyn, Elaine
    FRONTIERS IN PUBLIC HEALTH, 2023, 11
  • [8] COVID-19 Vaccine Hesitancy
    Storey, Doug
    GLOBAL HEALTH-SCIENCE AND PRACTICE, 2022, 10 (01):
  • [9] COVID-19 vaccine hesitancy
    Eve Dubé
    Noni E. MacDonald
    Nature Reviews Nephrology, 2022, 18 : 409 - 410
  • [10] COVID-19 vaccine hesitancy
    Dube, Eve
    MacDonald, Noni E.
    NATURE REVIEWS NEPHROLOGY, 2022, 18 (07) : 409 - 410